Maria Figueroa

Associate Professor

  • 10982 Citations
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Maria Figueroa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
DNA Methylation Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Methylation Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Mutation Medicine & Life Sciences
decitabine Medicine & Life Sciences
Cytosine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2023

Organized Financing
Myelodysplastic Syndromes

Research Output 2006 2019

A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes

Fernandez, A. G. L., Crescenzi, B., Pierini, V., Di Battista, V., Barba, G., Pellanera, F., Di Giacomo, D., Roti, G., Piazza, R., Adelman, E. R., Figueroa, M. & Mecucci, C., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Open Access
Myelodysplastic Syndromes
6 Citations (Scopus)

IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response

Núñez, F. J., Mendez, F. M., Kadiyala, P., Alghamri, M. S., Savelieff, M. G., Garcia-Fabiani, M. B., Haase, S., Koschmann, C., Calinescu, A. A., Kamran, N., Saxena, M., Patel, R., Carney, S., Guo, M. Z., Edwards, M., Ljungman, M., Qin, T., Sartor, M. A., Tagett, R., Venneti, S. & 15 others, Brosnan-Cashman, J., Meeker, A., Gorbunova, V., Zhao, L., Kremer, D. M., Zhang, L., Lyssiotis, C. A., Jones, L., Herting, C. J., Ross, J. L., Hambardzumyan, D., Hervey-Jumper, S., Figueroa, M., Lowenstein, P. R. & Castro, M. G., Feb 13 2019, In : Science Translational Medicine. 11, 479, eaaq1427.

Research output: Contribution to journalArticle

X-Linked Genes
DNA Damage

Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes

Qin, T., Sotzen, J., Rampal, R. K., Rapaport, F. T., Levine, R. L., Klimek, V., Nimer, S. D. & Figueroa, M., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Disease Progression
11 Citations (Scopus)

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia

Santini, V., Allione, B., Zini, G., Gioia, D., Lunghi, M., Poloni, A., Cilloni, D., Sanna, A., Masiera, E., Ceccarelli, M., Abdel-Wahab, O., Terenzi, A., Angelucci, E., Finelli, C., Onida, F., Pelizzari, A., Ferrero, D., Saglio, G., Figueroa, M. & Levis, A., Feb 1 2018, In : Leukemia. 32, 2, p. 413-418 6 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Multicenter Studies
1 Citation (Scopus)

Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells

Jin, X., Qin, T., Zhao, M., Bailey, N., Liu, L., Yang, K., Ng, V., Higashimoto, T., Coolon, R., Ney, G., Figueroa, M. & Li, Q., Jun 12 2018, In : Blood advances. 2, 11, p. 1259-1271 13 p.

Research output: Contribution to journalArticle

Open Access
Hematopoietic Stem Cells
Leukemia, Myelomonocytic, Chronic